There Is Now a GLP-1 Pill On April 1, 2026, the FDA approved orforglipron (Foundayo) from Eli Lilly
Alternative Energizing Strategies Caffeine is, for the most part, perfectly harmless and quite potent if dosed appropriately, but its not for everyone
Phase 2 study data highlights significant, dose-dependent improvements in lipid profiles at 48 weeks
Lean Mass Preservation: GLP-1 treatment is effective in promoting weight loss
IV formulations are prepared in accordance with applicable sterile compounding standards (USP ) and sourced from FDA-registered pharmacies
IL-1RA dampens the pro-inflammatory effects of IL-1, preventing excessive inflammation and mitigating neuroinflammatory processes associated with neurological disorders (reviewed in: 39 )